Anaphylactoid reactions during hemodialysis in sheep are ACE inhibitor dose-dependent and mediated by bradykinin

Kidney International

Volumn 53, Issue 4, 1998, Pages 1026-1035

  Krieter, Detlef H ^a   Grude, Matthias ^b   Lemke, Horst Dieter ^b   Fink, Edwin ^b   Bönner, Gerd ^b   Schölkens, Bernward A ^b   Schulz, Egbert ^b   Müller, Gerhard A ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b NONE

Author keywords

ACE inhibition; AN69 membrane; Bradykinin; Icatibant; Membrane biocompatibility; Polyacrylonitrile membranes

Indexed keywords

BRADYKININ; BRADYKININ B2 RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL MALEATE; HIGH MOLECULAR WEIGHT KININOGEN; ICATIBANT; POLYACRYLONITRILE; PREKALLIKREIN;

ANAPHYLAXIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIALYSIS MEMBRANE; DOSE RESPONSE; FEMALE; HEMODIALYSIS; HYPOTENSION; INTRAVENOUS DRUG ADMINISTRATION; MEDIATOR; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SHEEP;

EID: 0031979879     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00837.x     Document Type: Article

References (41)

1. TIELEMANS C, MADHOUN P, LENAERS M, SCHANDENE L, GOLDMAN M, VANHERWEGHEM JL: Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors. Kidney Int 38:982-984, 1990
2. VERRESEN L, WAER M, VANRENTERGHEM Y, MICHIELSEN P: Angiotensin-converting-enzyme inhibitors and anaphylactoid reactions to high-flux membrane dialysis. Lancet 336:1360-1362, 1990
3. ALVAREZ-LARA MA, MARTIN-MALO A, ESPINOSA M, CASTILLO D, ALJAMA P: ACE inhibitors and anaphylactoid reactions to high-flux membrane dialysis. (letter) Lancet 337:370, 1991
4. TIELEMANS C, VANHERWEGHEM JL, BLUMBERG A, CUVELIER R, DE FREMONT JF, DEHOUT F, DUPONT P, RICHARD C, STOLEAR JC, WENS R: ACE inhibitors and anaphylactoid reactions to high-flux membrane dialysis. (letter) Lancet 337:370-371, 1991
5. JADOUL M, STRUYVEN J, STRAGIER A, VAN YPERSELE DE STRIHOU C: ACE inhibitors and anaphylactoid reactions to high-flux membrane dialysis. (letter) Lancet 337:112, 1991
6. VAN ES A, HENNY FC, LOBATTO S: ACE inhibitors and anaphylactoid reactions to high-flux membrane dialysis. (letter) Lancet 337:112-113, 1991
7. CARAVACA F, PIZARRO JL, GARCIA MC, CUBERO JJ, ARROBAS M, ESPARRAGO JS, SANCHEZ-CASADO E: More about anaphylactoid reactions in patients dialyzed with AN69 filter and on angiotensin converting enzyme inhibitors treatment. (letter) Nephron 60:372-373, 1992
8. LEMKE HD, FINK E: Accumulation of bradykinin formed by the AN69-or PAN 17DX-membrane is due to the presence of an ACE inhibitor in vitro. (abstract) J Am Soc Nephrol 10:376, 1992
9. FINK E, LEMKE HD, VERRESEN L, SHIMAMOTO K: Kinin generation by hemodialysis membranes as a possible cause of anaphylactoid reactions. Brazilian J Med Biol Res 27:1975-1983, 1994
10. KRIETER DH, FINK E, BÖNNER G, YOU HM, EISENHAUER T: Anaphylactoid reactions during haemodialysis in sheep are associated with bradykinin release. Nephrol Dial Transplant 10:509-513, 1995
11. VERRESEN L, FINK E, LEMKE HD, VANRENTERGHEM Y: Bradykinin is a mediator of anaphylactoid reactions during hemodialysis with AN69 membranes. Kidney Int 45:1497-1503, 1994
12. WIRTH KJ, HEITSCH H, SCHÖLKENS BA: Kinin receptor antagonists: Unique probes in basic and clinical research. Can J Physiol Pharmacol 73:797-804, 1995
13. DAVIDSON DC, PEART I, TURNER S, SANGSTER M: Prevention with Icatibant of anaphylactoid reactions to ACE inhibitor during LDL apheresis. (letter) Lancet 343:1575, 1994
14. SHIMAMOTO K, ANDO T, TANAKA S, IIMURA O: The determination of kinin and glandular kallikrein in human biological fluids. Atemw-Lungenkrkh 1(Suppl 14):29-36, 1988
15. FINK E, SCHILL W-B, FIEDLER F, KRASSNIGG F, GEIGER R, SHIMAMOTO K: Tissue kallikrein of human seminal plasma is secreted by the prostate gland. Biol Chem Hoppe-Seyler 366:917-924, 1985
16. BOENNER G, HORN J, BUECHSLER U, KAPP C: Measurement of plasma prokallikrein independent of inhibitors and interfering enzymes, in Kinins IV, Part B, edited by GREENBAUM LM, MARGOLIUS HS, New York, Plenum Publishing Corporation, 1986, pp 87-98
17. UCHIDA Y, KATORI M: Differential assay method for high molecular weight and low molecular weight kininogens. Thromb Res 15:127-134, 1979
18. SCHULMAN G, HAKIM R, ARIAS R, SILVERBERG, M, KAPLAN AP, ARBEIT L: Bradykinin generation by dialysis membranes: Possible role in anaphylactic reactions. J Am Soc Nephrol 3:1563-1569, 1993
19. ARBEIT LA, SCHULMAN G, HOLMES T, CHEN A, RAMSAMMY LS: The binding of vasoactive substances to dialysis membranes is proportional to the negativity of the surface potential. (abstract) Proceedings of the Xth International Society of Nephrology 1987, p 122
20. MATSUDA T: Biological responses at non-physiological interfaces and molecular design of biocompatible surfaces. Nephrol Dial Transplant 4(Suppl):60-66, 1989
21. BÖNNER G: Kallikrein-kinin systems in shock, in Handbook of Mediators in Septic Shock, edited by NEUGEBAUER E, HOLADAY JW, Boca Raton, CRC Press, Inc., 1993, pp 167-192
22. MAZUECOS A, MONTOYO C, ANDRES A, CAMPO M, PRAGA M: Absence of anaphylactoid reactions with the combined use of ACE inhibitors and AN69 hemodialysis membranes. (letter) Nephron 59: 519, 1991
23. TERUEL JL, PASCUAL J, SERRANO P, ORTUNO J: ACE inhibitors and AN69 membranes: Absence of anaphylactoid reactions in hemodiafiltration process. (abstract) Nephrol Dial Transplant 7:275, 1992
24. VAN DER NIEPEN P, SENNESAEL JS, VERBEELEN DL, VAN INGELGEM D: Prevention of anaphylactoid reactions to high-flux membrane dialysis and ACE inhibitors by calcium. Nephrol Dial Transplant 9:87-89, 1993
25. PARNES EL, SHAPIRO WB: Anaphylactoid reactions in hemodialysis patients treated with the AN69 dialyzer. Kidney Int 40:1148-1152, 1991
26. VAN DER NIEPEN P, SENNESAEL JJ, VERBEELEN DL: Kinin kinetics during different dialysis protocols with AN69 dialyser in ACEI-treated patients. Nephrol Dial Transplant 10:1689-1695, 1995
27. SCHAEFER RM, FINK E, SCHAEFER L, BARKHAUSEN R, KULZER P, HEIDLAND A: Role of bradykinin in anaphylactoid reactions during hemodialysis with AN 69 dialyzers. Am J Nephrol 13:473-477, 1993
28. AKIZAWA T, KINUGASA E, WAKASA M, KOHJIRO S, KOIWA F, KOSHIKAWA S: Effect of dialysis membranes and ACE inhibitor on bradykinin levels during hemodialysis. Clin Nephrol 41:241-244, 1994
29. BÖNNER G, PREIS S, SCHUNK U, TOUSSINT C, KAUFMANN W: Hemodynamic effects of bradykinin on systemic and pulmonary circulation in healthy and hypertensive humans. J Cardiovasc Pharmacol 15(Suppl 6):46-56, 1992
30. BÖNNER G, PREIS S, SCHUNK U, IWERSEN D: Hemodynamic effects of kinins and their role in blood pressure regulation, in The Kallikrein-Kinin System in Health and Disease, edited by FRITZ H, SCHMIDT I, DIETZE G, Limbach-Verlag Braunschweig, 1989, pp 79-96
31. BÖNNER G, PREIS S, SCHUNK U, WAGMANN M, CHROSCH R, TOUSSINT C: Effect of bradykinin on arteries and veins in systemic and pulmonary circulation. J Cardiovasc Pharmacol 20(Suppl 9):21-27, 1942
32. 2-kininreceptor antagonist, measured by bradykinin injections - A dose finding study. (abstract) Am J Hypertens 7:137A, 1994
33. BOENNER G, CHROSCH R, RUETTEN H, MUELLER R, KRAUSE E: Role of kinins in basal blood pressure regulation in man. Evaluation by the kinin B2-receptor antagonist HOE 140. Eur J Clin Invest 25(Suppl 2):A8, 1995
34. HOCK FJ, WIRTH K, ALBUS U, LINZ W, GERHARDS HJ, WIEMER G, HENKE S, BREIPOHL G, KÖNIG W, KNOLLE J, SCHOELKENS BA: Hoe 140 a new potent and long acting bradykinin-antagonist: In vitro studies. Br J Pharmacol 102:769-773, 1991
35. THURIEAU C, FÉLÉTOU M, CANET E, FAUCHÈRE JL: P-Guanidinobenzoyl-[Hyp3, Thi5, D-Tic7, Oic8]bradykinin is almost completely devoid of the agonist effect of HOE140 on the endothelium-free femoral artery of sheep. Bioorg Med Chem Lett 4:781-784, 1994
36. LIEBERMANN J: Elevation of serum angiotensin-converting enzyme (ACE) level in sarcoidosis. Am J Med 59:365-372, 1975
37. ROSCHER A, KLIER C, DENGLER R, FAUBNER A, MÜLLER-ESTERI W: Regulation of bradykinin action at the receptor level. J Cardiovasc Pharmacol 15(Suppl 6):39, 1990
38. SMITH DHG, NEUTEL JM, WEBER MA: Effects of angiotensin II on pressor responses to norepinephrine in humans. (abstract) Life Sci 48:2413, 1991
39. JUST PM: The positive association of cough with angiotensin-converting enzyme inhibitors. Pharmacotherapy 9:82-87, 1989
40. LEMKE HD, FINK E: Generation of bradykinin in human plasma by different membranes in the presence of an ACE inhibitor. (abstract) XXIXth Congress of the EDTA, 1992, p 163
41. MANNSTADT M, TOUAM M, FINK E, URENA P, HRUBY M, ZINGRAFF J, UHLENBUSCH-KÖRWER I, GRASSMANN A, LEMKE HD, DRÜECKE TB: No generation of bradykinin with a new polyacrylonitrile membrane (SPAN) in haemodialysis patients treated with ACE inhibitors. Nephrol Dial Transplant 10:1696-1700, 1995